CoChat

Indirect neonatal hyperbilirubinemia in hospitalized neonates on the Thai-Myanmar border: a review of neonatal medical records from 2009 to 2014

Open access
Thielemans, L., Trip-Hoving, M., Landier, J., Turner, C., Prins, T. J., Wouda, E. M. N., Hanboonkunupakarn, B., Po, C., Beau, C., Mu, M., Hannay, T., Nosten, F., Van Overmeire, B., McGready, R., Carrara, V. I. · 2018 · BMC Pediatrics
Cited by 34

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Indirect neonatal hyperbilirubinemia (INH) is a common neonatal disorder worldwide which can remain benign if prompt management is available. However there is a higher morbidity and mortality risk in settings with limited access to diagnosis and care. The manuscript describes the characteristics of neonates with INH, the burden of severe INH and identifies factors associated with severity in a resource-constrained setting. METHODS: We conducted a retrospective evaluation of anonymized records of neonates hospitalized on the Thai-Myanmar border. INH was defined according to the National Institute for Health and Care Excellence guidelines as 'moderate' if at least one serum bilirubin (SBR) value exceeded the phototherapy threshold and as 'severe' if above the exchange transfusion threshold. RESULTS: Out of 2980 records reviewed, 1580 (53%) had INH within the first 14 days of life. INH was moderate in 87% (1368/1580) and severe in 13% (212/1580). From 2009 to 2011, the proportion of severe INH decreased from 37 to 15% and the mortality dropped from 10% (8/82) to 2% (7/449) coinciding with the implementation of standardized guidelines and light-emitting diode (LED) phototherapy. Severe INH was associated with: prematurity (< 32 weeks, Adjusted Odds Ratio (AOR) 3.3; 95% CI 1.6-6.6 and 32 to 37 weeks, AOR 2.2; 95% CI 1.6-3.1), Glucose-6-phosphate dehydrogenase deficiency (G6PD) (AOR 2.3; 95% CI 1.6-3.3), potential ABO incompatibility (AOR 1.5; 95% CI 1.0-2.2) and late presentation (AOR 1.8; 95% CI 1.3-2.6). The risk of developing severe INH and INH-related mortality significantly increased with each additional risk factor. CONCLUSION: INH is an important cause of neonatal hospitalization on the Thai-Myanmar border. Risk factors for severity were similar to previous reports from Asia. Implementing standardized guidelines and appropriate treatment was successful in reducing mortality and severity. Accessing to basic neonatal care including SBR testing, LED phototherapy and G6PD screening can contribute to improve neonatal outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12887-018-1165-0

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 42

  1. Bhutani VK, Zipursky A, Blencowe H, Khanna R, Sgro M, Ebbesen F, et al. Neonatal hyperbilirubinemia and rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res. 2013;74(Suppl 1):86–100. · DOI · Paper page
  2. Shapiro SM. Chronic bilirubin encephalopathy: diagnosis and outcome. Semin Fetal Neonatal Med. 2010;15:157–63. Elsevier Ltd · doi:10.1016/j.siny.2009.12.004
  3. Radmacher PG, Groves FD, Owa JA, Ofovwe GE, Amuabunos EA, Olusanya BO, et al. A modified bilirubin-induced neurologic dysfunction (BIND-M) algorithm is useful in evaluating severity of jaundice in a resource-limited setting. BMC Pediatr. 2015;15:1–7. · doi:10.1186/s12887-015-0355-2
  4. Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the pilot USA kernicterus registry (1992 to 2004). J Perinatol. 2009;29(Suppl 1):S25–45. · DOI · Paper page
  5. Lawn JE, Blencowe H, Oza S, You D, Lee ACC, Waiswa P, et al. Every newborn: progress, priorities, and potential beyond survival. Lancet. 2014;384:189–205. · DOI · Paper page
  6. Greco C, Arnolda G, Boo NY, Iskander IF, Okolo AA, Rohsiswatmo R, et al. Neonatal jaundice in low- and middle-income countries: lessons and future directions from the 2015 don Ostrow Trieste yellow retreat. Neonatology. 2016;110:172–80. · DOI · Paper page
  7. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379:2162–72. · DOI · Paper page
  8. Howes RE, Piel FBFB, Patil AP, Nyangiri OA, Gething PW, Dewi M, et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2012;9(11):e1001339. · DOI · Paper page
  9. Bhutani VK. Editorial: building evidence to manage newborn jaundice worldwide. Indian J Pediatr. 2012;79(2):253–5. · doi:10.1007/s12098-011-0631-6
  10. Naghavi M, Wang H, Lozano R, Davis A, Liang X, Zhou M, et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;385:117–71. · DOI · Paper page
  11. Arnolda G, Nwe HM, Trevisanuto D, Thin AA, Thein AA, Defechereux T, et al. Risk factors for acute bilirubin encephalopathy on admission to two Myanmar national paediatric hospitals. Maternal health, neonatology and perinatology. 2015;1:22. · DOI
  12. Oo NN, Bancone G, Maw LZ, Chowwiwat N, Bansil P, Domingo GJ, et al. Validation of G6PD point-of-care tests among healthy volunteers in Yangon, Myanmar. PLoS One. 2016;11:e0152304. · DOI
  13. Webster J, Blythe R, Nugent F. An appraisal of the use of the Kramer’s scale in predicting hyperbilirubinaemia in healthy full term infants. Birth Issues. 2006;14:83–9.
  14. Howson CP, Kinney MV, Lawn JE, editors. Born too soon: the global action report on preterm birth. Geneva: World Health Organization; 2012. p. 1–26.
  15. Turner C, Carrara V, Aye N, Thien M, Moo N, Paw K, et al. Changes in the body weight of term infants, born in the tropics, during the first seven days of life. BMC Pediatr. 2013;13(1):93. · DOI
  16. Rijken MJ, Rijken JA, Papageorghiou AT, Kennedy SH, Visser GHA, Nosten F, et al. Malaria in pregnancy: the difficulties in measuring birthweight. BJOG Int J Obstet Gynaecol. 2011;118(6):671–8. · DOI · Paper page
  17. Villar J, Cheikh Ismail L, Victora CG, Ohuma EO, Bertino E, Altman DG, et al. International standards for newborn weight, length, and head circumference by gestational age and sex: the newborn cross-sectional study of the INTERGROWTH-21st project. The Lancet. 2014;384:857–68. · DOI · Paper page
  18. Mya-Tu M, May-May-Yi M, Thin-Thin-Hlaing T. Blood groups of the Burmese population. Hum Hered. 1971;21:420–30. · doi:10.1159/000152435
  19. Basu S, Ravneet K, Gagandeep K. Hemolytic disease of the fetus and newborn: current trends and perspectives. Asian J Transfus Sci. 2011;5:3–7. · DOI
  20. Slusher TM, Zamora TG, Appiah D, Stanke JU, Strand MA, Lee BW, et al. Burden of severe neonatal jaundice: a systematic review and meta-analysis. BMJ Paediatr Open. 2017;1:e000105. · DOI · Paper page
  21. Szabo P, Wolf M, Bucher HU, Fauchère JC, Haensse D, Arlettaz R. Detection of hyperbilirubinaemia in jaundiced full-term neonates by eye or by bilirubinometer? Eur J Pediatr. 2004;163:722–7. · DOI
  22. Keren R, Tremont K, Luan X, Cnaan A. Visual assessment of jaundice in term and late preterm infants. Arch Dis Child Fetal Neonatal Ed. 2009;94:F317–22. · doi:10.1136/adc.2008.150714
  23. Tikmani SS, Warraich HJ, Abbasi F, Rizvi A, Darmstadt GL, Zaidi AKM. Incidence of neonatal hyperbilirubinemia: a population-based prospective study in Pakistan. Trop Med Int Heal. 2010;15:502–7. · doi:10.1111/j.1365-3156.2010.02496.x
  24. Sherbiny HS, Youssef DM, Sherbini AS, El-behedy R, Sherief LM. High-intensity light-emitting diode vs fluorescent tubes for intensive phototherapy in neonates. Paediatrics and international child health. 2016;36(2):127–34. · doi:10.1179/2046905515y.0000000006
  25. Arnolda G, Thein AA, Trevisanuto D, Aung N, Nwe HM, Thin AA, et al. Evaluation of a simple intervention to reduce exchange transfusion rates among inborn and outborn neonates in Myanmar, comparing pre- and post-intervention rates. BMC Pediatr. 2015;15:216. · DOI
  26. Olusanya BO, Osibanjo FB, Slusher TM. Risk factors for severe neonatal hyperbilirubinemia in low and middle-income countries: a systematic review and meta-analysis. PLoS One. 2015;10(2):e0117229. · DOI · Paper page
  27. Bancone G, Gilder ME, Chowwiwat N, Gornsawun G, Win E, Cho WW, et al. Prevalences of inherited red blood cell disorders in pregnant women of different ethnicities living along the Thailand-Myanmar border. Wellcome Open Res. 2017;2:1–17. · DOI · Paper page
  28. Thielemans L, Gornsawun G, Hanboonkunupakarn B, Paw MK, Porn P, Moo PK, et al. Diagnostic performances of the fluorescent spot test for G6PD deficiency in newborns along the Thailand-Myanmar border: a cohort study. Wellcome Open Res. 2018;3:1. · DOI · Paper page
  29. Kaplan M, Hammerman C. Glucose-6-phosphate dehydrogenase deficiency and severe neonatal hyperbilirubinemia: a complexity of interactions between genes and environment. Semin Fetal Neonatal Med. 2010;15:148–56. Elsevier Ltd · DOI
  30. Kaplan M, Herschel M, Hammerman C, Hoyer JD, Stevenson DK. Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics. 2004;114:e213–9. · DOI
  31. Watchko JF, Kaplan M, Stark AR, Stevenson DK, Bhutani VK. Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States? J Perinatol. 2013;33:499–504. Nature Publishing Group · DOI
  32. Olusanya BO, Osibanjo FB, Mabogunje CA, Slusher TM, Olowe SA. The burden and management of neonatal jaundice in Nigeria: a scoping review of the literature. Niger J Clin Pract. 2016;19(1):1–7. · DOI
  33. Malla T, Singh S, Poudyal P, Sathian B, Bk G, Malla KKA. Prospective study on exchange transfusion in neonatal unconjugated hyperbilirubinemia--in a tertiary care hospital, Nepal. Kathmandu Univ Med J. 2015;13:102–8. · doi:10.3126/kumj.v13i2.16781
  34. Singla DA, Sharma S, Sharma M, Chaudhary S. Evaluation of risk factors for exchange range hyperbilirubinemia and neurotoxicity in neonates from hilly terrain of India. Int J Appl basic Med Res. 2017;7:228–32. Wolters Kluwer -- Medknow Publications · doi:10.4103/2229-516x.198501
  35. Cherepnalkovski AP, Krzelj V, Zafirovska-ivanovska B, Gruev T, Markic J, et al. Evaluation of neonatal laboratory parameters hemolytic Jaundice : clinical and laboratory parameters. OA Maced J Med Sci. 2015;3:694–8. · doi:10.3889/oamjms.2015.129
  36. Chen S-H, Lin M, Yang K-L, Lin T-Y, Tsai H-H, Yang S-H, et al. Association of ABO incompatibility with red blood cell indices of cord blood unit. Pediatr Neonatol. 2012;53:138–43. · doi:10.1016/j.pedneo.2012.01.012
  37. Cherepnalkovski AP, Krzelj V, Zafirovska-ivanovska B, Gruev T, Markic J, Aluloska N, et al. Evaluation of neonatal laboratory parameters hemolytic Jaundice: clinical and laboratory parameters. OA Maced J Med Sci. 2015;3:694–8. · doi:10.3889/oamjms.2015.129
  38. Olusanya BO, Slusher TM. Infants at risk of significant hyperbilirubinemia in poorly-resourced countries: evidence from a scoping review. World J Pediatr. 2015;11:293–9. · DOI
  39. Kaplan M, Herschel M, Hammerman C, Hoyer JD, Heller GZ, Stevenson DK. Neonatal hyperbilirubinemia in African American males: the importance of glucose-6-phosphate dehydrogenase deficiency. J Pediatr. 2006;149:83–8. Elsevier · DOI
  40. Kaplan M, Hammerman C, Bhutani VK. Parental education and the WHO neonatal G-6-PD screening program: a quarter century later. J Perinatol. 2015;35:779–84. Nature Publishing Group · doi:10.1038/jp.2015.77
  41. Bhutani VK, Wong RJ, Stevenson DK. Hyperbilirubinemia in Preterm Neonates. Clin Perinatol. 2016;43(2):215–32. · DOI
  42. Davies MW, Okwundu CI, Okoromah CAN, Shah PS. Cochrane review: prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants. Evidence-Based Child Heal. 2013;8:204–49. · DOI

Cited by

See all 34

Metadata

Authors
Thielemans, L., Trip-Hoving, M., Landier, J., Turner, C., Prins, T. J., Wouda, E. M. N., Hanboonkunupakarn, B., Po, C., Beau, C., Mu, M., Hannay, T., Nosten, F., Van Overmeire, B., McGready, R., & Carrara, V. I.
Venue
BMC Pediatrics
Published
2018-06-12
Volume
18
Issue
1
Pages
190-190
ISSN
1471-2431 (ISSN-L)
OpenAlex
W2807718004
Cited by
34
References
10
FWCI
3.68
Type
journal article
Language
en
Open access
gold
Licence
creativecommons.org/licenses/by/4.0/ (tdm)
Funders
The Belgian Kids' Fund for Pediatric Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Indirect neonatal hyperbilirubinemia in hospitalized neonates on the Thai-Myanmar border: a review of neonatal medical records from 2009 to 2014. https://app.cochat.ai/papers/10.1186/s12887-018-1165-0
The paper
Thielemans, L., Trip-Hoving, M., Landier, J., Turner, C., Prins, T. J., Wouda, E. M. N., Hanboonkunupakarn, B., Po, C., Beau, C., Mu, M., Hannay, T., Nosten, F., Van Overmeire, B., McGready, R., & Carrara, V. I. (2018). Indirect neonatal hyperbilirubinemia in hospitalized neonates on the Thai-Myanmar border: a review of neonatal medical records from 2009 to 2014. BMC Pediatrics. https://doi.org/10.1186/s12887-018-1165-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.